Literature DB >> 30343956

ARNT as a Novel Antifibrotic Target in CKD.

Volker H Haase1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30343956      PMCID: PMC6348016          DOI: 10.1053/j.ajkd.2018.08.009

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  21 in total

Review 1.  Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.

Authors:  Naim Issa; Aleksandra Kukla; Hassan N Ibrahim
Journal:  Am J Nephrol       Date:  2013-06-18       Impact factor: 3.754

2.  Targeting renal cell carcinoma with a HIF-2 antagonist.

Authors:  Wenfang Chen; Haley Hill; Alana Christie; Min Soo Kim; Eboni Holloman; Andrea Pavia-Jimenez; Farrah Homayoun; Yuanqing Ma; Nirav Patel; Paul Yell; Guiyang Hao; Qurratulain Yousuf; Allison Joyce; Ivan Pedrosa; Heather Geiger; He Zhang; Jenny Chang; Kevin H Gardner; Richard K Bruick; Catherine Reeves; Tae Hyun Hwang; Kevin Courtney; Eugene Frenkel; Xiankai Sun; Naseem Zojwalla; Tai Wong; James P Rizzi; Eli M Wallace; John A Josey; Yang Xie; Xian-Jin Xie; Payal Kapur; Renée M McKay; James Brugarolas
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

Review 3.  Diverse structures, functions and uses of FK506 binding proteins.

Authors:  Julia Maeve Bonner; Gabrielle L Boulianne
Journal:  Cell Signal       Date:  2017-06-23       Impact factor: 4.315

4.  The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.

Authors:  S M Wood; J M Gleadle; C W Pugh; O Hankinson; P J Ratcliffe
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

Review 5.  Tacrolimus-induced nephrotoxicity and genetic variability: a review.

Authors:  Violette M G J Gijsen; Parvaz Madadi; Marie-Pierre Dube; Dennis A Hesselink; Gideon Koren; Saskia N de Wildt
Journal:  Ann Transplant       Date:  2012 Apr-Jun       Impact factor: 1.530

Review 6.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

7.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

8.  Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension.

Authors:  Edda Spiekerkoetter; Yon K Sung; Deepti Sudheendra; Matthew Bill; Micheala A Aldred; Mariëlle C van de Veerdonk; Anton Vonk Noordegraaf; Janel Long-Boyle; Rajesh Dash; Phillip C Yang; Allan Lawrie; Andrew J Swift; Marlene Rabinovitch; Roham T Zamanian
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

9.  Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2012-02-05       Impact factor: 53.440

10.  On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models.

Authors:  Hyejin Cho; Xinlin Du; James P Rizzi; Ella Liberzon; Abhishek A Chakraborty; Wenhua Gao; Ingrid Carvo; Sabina Signoretti; Richard K Bruick; John A Josey; Eli M Wallace; William G Kaelin
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

View more
  3 in total

1.  Cholesterol Metabolism in Chronic Kidney Disease: Physiology, Pathologic Mechanisms, and Treatment.

Authors:  Xiaoyue Pan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?

Authors:  Yenan Mo; Zhaoyu Lu; Lixin Wang; Chunlan Ji; Chuan Zou; Xusheng Liu
Journal:  Front Cell Dev Biol       Date:  2020-12-07

3.  PP2A phosphatase inhibition is anti-fibrotic through Ser77 phosphorylation-mediated ARNT/ARNT homodimer formation.

Authors:  Gunsmaa Nyamsuren; Gregor Rapp; Björn Tampe; Michael Zeisberg; Hassan Dihazi; Elisabeth M Zeisberg; Desiree Tampe
Journal:  Sci Rep       Date:  2021-12-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.